Outcome | OR (95% CI) | p-value |
---|---|---|
Overall | ||
Time | 0.93 (0.92–0.94) | < 0.0001 |
Group (changeover group vs control group) | 1.03 (0.97–1.09) | 0.33 |
Intervention (after intervention vs before intervention) | 1.04 (0.95–1.15) | 0.39 |
Group*Intervention | 1.03 (0.94–1.13) | 0.53 |
Reallocated by primary diagnosis | ||
Medical | ||
Time | 0.93 (0.92–0.95) | < 0.0001 |
Group (changeover group vs control group) | 1.02 (0.95–1.09) | 0.60 |
Intervention (after intervention vs before intervention) | 1.01 (0.90–1.14) | 0.84 |
Group*Intervention | 1.04 (0.93–1.17) | 0.48 |
Surgical | ||
Time | 0.94 (0.91–0.96) | < 0.0001 |
Group (changeover group vs control group) | 1.06 (0.90–1.25) | 0.47 |
Intervention (after intervention vs before intervention) | 0.99 (0.73–1.33) | 0.93 |
Group*Intervention | 0.96 (0.78–1.20) | 0.96 |
Neoplasm | ||
Time | 0.93 (0.90–0.96) | < 0.0001 |
Group (changeover group vs control group) | 1.08 (0.91–1.28) | 0.38 |
Intervention (after intervention vs before intervention) | 1.45 (1.06–1.96) | 0.02 |
Group*Intervention | 1.04 (0.82–1.33) | 0.75 |